Chronic Kidney Disease Management in Primary Care: Challenges and Possible Developments

Overview

Journal Br J Gen Pract

Specialty Public Health

Date 2025 Feb 27

PMID 40016109

Authors

Heather Walker

Michael K Sullivan

Bhautesh Dinesh Jani

Katie Gallacher

Affiliations

Soon will be listed here.

References

Martini A, Ammirati A, Garcia C, Andrade C, Portela O, Cendoroglo M . Evaluation of quality of life, physical, and mental aspects in longevous patients with chronic kidney disease. Int Urol Nephrol. 2018; 50(4):725-731. DOI: 10.1007/s11255-018-1813-1. View

Molokhia M, Okoli G, Redmond P, Asgari E, Shaw C, Schofield P . Uncoded chronic kidney disease in primary care: a cross-sectional study of inequalities and cardiovascular disease risk management. Br J Gen Pract. 2020; 70(700):e785-e792. PMC: 7575408. DOI: 10.3399/bjgp20X713105. View

Astor B, Hallan S, Miller 3rd E, Yeung E, Coresh J . Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008; 167(10):1226-34. DOI: 10.1093/aje/kwn033. View

Duff R, Awofala O, Arshad M, Lambourg E, Gallacher P, Dhaun N . Global health inequalities of chronic kidney disease: a meta-analysis. Nephrol Dial Transplant. 2024; 39(10):1692-1709. PMC: 11483576. DOI: 10.1093/ndt/gfae048. View

Fraser S, Roderick P, Aitken G, Roth M, Mindell J, Moon G . Chronic kidney disease, albuminuria and socioeconomic status in the Health Surveys for England 2009 and 2010. J Public Health (Oxf). 2013; 36(4):577-86. DOI: 10.1093/pubmed/fdt117. View

Kittipibul V, Cox Z, Chesdachai S, Fiuzat M, Lindenfeld J, Mentz R . Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors: JACC Review Topic of the Week. J Am Coll Cardiol. 2024; 83(16):1568-1578. DOI: 10.1016/j.jacc.2024.01.040. View

. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022; 102(5S):S1-S127. DOI: 10.1016/j.kint.2022.06.008. View

Major R, Brown C, Shepherd D, Rogers S, Pickering W, Warwick G . The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease (PSP-CKD) Study: A Cluster Randomized Trial in Primary Care. J Am Soc Nephrol. 2019; 30(7):1261-1270. PMC: 6622412. DOI: 10.1681/ASN.2018101042. View

Roddick A, Wonnacott A, Webb D, Watt A, Watson M, Staplin N . UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE. BMC Nephrol. 2023; 24(1):310. PMC: 10598949. DOI: 10.1186/s12882-023-03339-3. View

10.

Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M . Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006; 17(7):2034-47. DOI: 10.1681/ASN.2005101085. View

11.

Kovesdy C . Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022; 12(1):7-11. PMC: 9073222. DOI: 10.1016/j.kisu.2021.11.003. View

12.

Tangri N, Stevens L, Griffith J, Tighiouart H, Djurdjev O, Naimark D . A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011; 305(15):1553-9. DOI: 10.1001/jama.2011.451. View

13.

Agarwal A, Zeng X, Li S, Rayner D, Foroutan F, Aertgeerts B . Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline. BMJ. 2024; 387:e080257. DOI: 10.1136/bmj-2024-080257. View

14.

Karam S, Wong M, Jha V . Sustainable Development Goals: Challenges and the Role of the International Society of Nephrology in Improving Global Kidney Health. Kidney360. 2023; 4(10):1494-1502. PMC: 10617794. DOI: 10.34067/KID.0000000000000237. View

15.

Vanholder R, Annemans L, Braks M, Brown E, Pais P, Purnell T . Inequities in kidney health and kidney care. Nat Rev Nephrol. 2023; 19(11):694-708. DOI: 10.1038/s41581-023-00745-6. View

16.

Sullivan M, Jani B, Rutherford E, Welsh P, McConnachie A, Major R . Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study. Br J Gen Pract. 2022; 73(727):e141-e147. PMC: 9678375. DOI: 10.3399/BJGP.2022.0145. View

17.

Major R, Shepherd D, Medcalf J, Xu G, Gray L, Brunskill N . The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study. PLoS Med. 2019; 16(11):e1002955. PMC: 6834237. DOI: 10.1371/journal.pmed.1002955. View

18.

Chu C, Powe N, Shlipak M, Scherzer R, Tummalapalli S, Estrella M . Albuminuria testing and nephrology care among insured US adults with chronic kidney disease: a missed opportunity. BMC Prim Care. 2022; 23(1):299. PMC: 9700954. DOI: 10.1186/s12875-022-01910-9. View

19.

Plantinga L, Tuot D, Powe N . Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis. 2010; 17(3):225-36. PMC: 2864779. DOI: 10.1053/j.ackd.2010.03.002. View

20.

Foreman K, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M . Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018; 392(10159):2052-2090. PMC: 6227505. DOI: 10.1016/S0140-6736(18)31694-5. View